Mirae Asset Global ETFs Holdings’s West Pharmaceutical WST Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.53M	Buy	18,652 +9,462	+103%	+$2.89M	0.01%	789
2026 Q1	$2.3M	Sell	9,190 -280	-3%	-$69.7K	﹤0.01%	1115
2025 Q4	$2.61M	Buy	9,470 +131	+1%	+$35.8K	﹤0.01%	1037
2025 Q3	$2.45M	Buy	9,339 +144	+2%	+$35K	﹤0.01%	1054
2025 Q2	$2.01M	Sell	9,195 -5,371	-37%	-$1.15M	﹤0.01%	1098
2025 Q1	$3.26M	Buy	14,566 +4,961	+52%	+$1.37M	0.01%	896
2024 Q4	$3.15M	Sell	9,605 -8,773	-48%	-$2.76M	0.01%	911
2024 Q3	$5.52M	Buy	18,378 +1,085	+6%	+$332K	0.01%	732
2024 Q2	$5.7M	Buy	+17,293	New	+$6.11M	0.01%	706

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's WST Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its West Pharmaceutical (WST) stake by 103% in Q2 2026, buying an estimated $2.89M and bringing the position to 18,652 shares worth $6.53M. The position accounts for 0.01% of the portfolio, ranked #789.

Mirae Asset Global ETFs Holdings first reported a position in WST in Q2 2024 and has held it in 9 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Mirae Asset Global ETFs Holdings held 18,652 shares of West Pharmaceutical worth $6.53M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 9,462 West Pharmaceutical shares in Q2 2026, an estimated $2.89M.
West Pharmaceutical made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #789 holding.
Mirae Asset Global ETFs Holdings first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.